Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew I Milowsky

Showing results (21-30 of 205) with videos related to

Pageof 21
Sort By:
BJU International|August 23, 2011
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?Arjun V Balar, Matthew I Milowsky
European Urology Focus|June 6, 2022
How to Conduct Clinical Trials of Personalized Cancer TherapiesSean Clark-Garvey, Matthew I Milowsky
European Urology|September 9, 2015
A Small Step Toward Improving Systemic Treatment for Metastatic Bladder Cancer--At What Cost?Tracy L Rose, Matthew I Milowsky
Expert Review of Anticancer Therapy|November 30, 2010
Novel strategies for treating relapsed/refractory urothelial carcinomaGopa Iyer, Matthew I Milowsky, Dean F Bajorin
Therapeutic Advances in Urology|September 10, 2011
Management of invasive bladder cancer in patients who are not candidates for or decline cystectomyArjun Balar, Dean F Bajorin, Matthew I Milowsky
Journal of Oncology Practice|April 13, 2018
Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: ASCO Clinical Practice Guideline SummaryMichael J Morris, R Bryan Rumble, Matthew I Milowsky
Cancer|July 17, 2008
Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line settingDavid J Gallagher, Matthew I Milowsky, Dean F Bajorin
BJU International|November 28, 2008
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancerMatthew I Milowsky, Walter M Stadler, Dean F Bajorin
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Optimizing systemic therapy for bladder cancerSumanta K Pal, Matthew I Milowsky, Elizabeth R Plimack
European Urology Oncology|June 2, 2023
Cancer Associated Fibroblasts: An Understudied but Critical Component of the Tumor Microenvironment in Urothelial CancerSean Clark-Garvey, Jeffrey S Damrauer, Matthew I Milowsky
Pageof 21

Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
BJU International|August 23, 2011
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?Arjun V Balar, Matthew I Milowsky
European Urology Focus|June 6, 2022
How to Conduct Clinical Trials of Personalized Cancer TherapiesSean Clark-Garvey, Matthew I Milowsky
European Urology|September 9, 2015
A Small Step Toward Improving Systemic Treatment for Metastatic Bladder Cancer--At What Cost?Tracy L Rose, Matthew I Milowsky
Expert Review of Anticancer Therapy|November 30, 2010
Novel strategies for treating relapsed/refractory urothelial carcinomaGopa Iyer, Matthew I Milowsky, Dean F Bajorin
Therapeutic Advances in Urology|September 10, 2011
Management of invasive bladder cancer in patients who are not candidates for or decline cystectomyArjun Balar, Dean F Bajorin, Matthew I Milowsky
Journal of Oncology Practice|April 13, 2018
Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: ASCO Clinical Practice Guideline SummaryMichael J Morris, R Bryan Rumble, Matthew I Milowsky
Cancer|July 17, 2008
Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line settingDavid J Gallagher, Matthew I Milowsky, Dean F Bajorin
BJU International|November 28, 2008
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancerMatthew I Milowsky, Walter M Stadler, Dean F Bajorin
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Optimizing systemic therapy for bladder cancerSumanta K Pal, Matthew I Milowsky, Elizabeth R Plimack
European Urology Oncology|June 2, 2023
Cancer Associated Fibroblasts: An Understudied but Critical Component of the Tumor Microenvironment in Urothelial CancerSean Clark-Garvey, Jeffrey S Damrauer, Matthew I Milowsky
Pageof 21